Back to CRVS

KELLEHER FINANCIAL ADVISORS → CRVS

KELLEHER FINANCIAL ADVISORS CRVS Position History

Corvus Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$864
Q3 2026
Peak value
$1K
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$553
Q4 2025$578
Q2 2026$1K
Q3 2026$864

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$86475——
Q2 2026$1K75——
Q4 2025$57875——
Q3 2025$55375——

Other funds holding CRVS

Other KELLEHER FINANCIAL ADVISORS positions

ETHA

iShares Trust S&P

$44.7M
ETHA

iShares Trust S&P

$44.6M
ETHA

ISHARES TR

$43.4M
BRK-A

BERKSHIRE HATHAWAY INC DEL CL A

$43M
ETHA

ISHARES TR

$42.6M
ETHA

iShares Trust S&P

$38.9M
BRK-A

BERKSHIRE HATHAWAY INC DEL CL A

$36.2M
BRK-A

BERKSHIRE HATHAWAY INC DEL

$35.9M
KELLEHER FINANCIAL ADVISORS CRVS Holdings: 13F Position History | Track13F